AZTA logo

Azenta (AZTA) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

02 February 1995

Indexes:

Not included

Description:

Azenta, formerly known as AZTA, is a global company that provides life sciences solutions. They specialize in sample management, genomic services, and laboratory automation. Azenta helps researchers and organizations improve their processes and accelerate discoveries in fields like healthcare and biotechnology.

Key Details

Price

$47.11

Annual Revenue

$656.32 M(-1.32% YoY)

Annual EPS

-$3.09(-1304.55% YoY)

Beta

1.24

Events Calendar

Earnings

Next earnings date:

Feb 07, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Nov 12, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Dec 02, 2021
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

13 Nov '24 Needham
Buy
01 Oct '24 Evercore ISI Group
In-Line
07 Aug '24 Needham
Buy
02 July '24 Evercore ISI Group
In-Line
09 May '24 Needham
Buy
08 Apr '24 Needham
Buy
04 Apr '24 Jefferies
Hold
04 Apr '24 Evercore ISI Group
In-Line
28 Mar '24 Needham
Buy
14 Mar '24 Needham
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Azenta to Participate in Stephens Annual Investment Conference
Azenta to Participate in Stephens Annual Investment Conference
Azenta to Participate in Stephens Annual Investment Conference
AZTA
prnewswire.com14 November 2024

BURLINGTON, Mass. , Nov. 14, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Stephens Annual Investment Conference, on Wednesday November 20, 2024, which includes a presentation beginning at 1:00 pm CT.

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
AZTA
prnewswire.com12 November 2024

FY'24 revenue growth of 4%, reported and organic, in combined Sample Management Solutions and Multiomics FY'25 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis points Pursuing a sale of B Medical Systems to simplify portfolio and drive revenue growth and profitability Announces appointment of Lawrence Y. Lin as Chief Financial Officer; Herman Cueto to remain as advisor to ensure smooth transition BURLINGTON, Mass.

Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
AZTA
prnewswire.com04 November 2024

BURLINGTON, Mass. , Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12, 2024, after the market closes.

AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO
AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO
AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO
AZTA
prnewswire.com04 September 2024

Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. , Sept. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P.

GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event
GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event
GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event
AZTA
prnewswire.com12 August 2024

BURLINGTON, Mass. , Aug. 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ Week event on September 16 - 20.

Azenta (AZTA) Q3 Earnings and Revenues Top Estimates
Azenta (AZTA) Q3 Earnings and Revenues Top Estimates
Azenta (AZTA) Q3 Earnings and Revenues Top Estimates
AZTA
zacks.com06 August 2024

Azenta (AZTA) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.13 per share a year ago.

Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
AZTA
prnewswire.com05 August 2024

BURLINGTON, Mass. , Aug. 5, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, on Monday, August 12, 2024.

Analysts Estimate Azenta (AZTA) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Azenta (AZTA) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Azenta (AZTA) to Report a Decline in Earnings: What to Look Out for
AZTA
zacks.com30 July 2024

Brooks (AZTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?
Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?
Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?
AZTA
zacks.com30 July 2024

Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately.

Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
AZTA
prnewswire.com24 July 2024

BURLINGTON, Mass. , July 24, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024, on Tuesday, August 6, 2024, after the market closes.

  • 1(current)
  • 2
  • 3
  • 1(current)
  • 2
  • 3

FAQ

  • What is the primary business of Azenta?
  • What is the ticker symbol for Azenta?
  • Does Azenta pay dividends?
  • What sector is Azenta in?
  • What industry is Azenta in?
  • What country is Azenta based in?
  • When did Azenta go public?
  • Is Azenta in the S&P 500?
  • Is Azenta in the NASDAQ 100?
  • Is Azenta in the Dow Jones?
  • When was Azenta's last earnings report?
  • When does Azenta report earnings?
  • Should I buy Azenta stock now?

What is the primary business of Azenta?

Azenta, formerly known as AZTA, is a global company that provides life sciences solutions. They specialize in sample management, genomic services, and laboratory automation. Azenta helps researchers and organizations improve their processes and accelerate discoveries in fields like healthcare and biotechnology.

What is the ticker symbol for Azenta?

The ticker symbol for Azenta is NASDAQ:AZTA

Does Azenta pay dividends?

No, Azenta does not pay dividends

What sector is Azenta in?

Azenta is in the Healthcare sector

What industry is Azenta in?

Azenta is in the Medical Instruments & Supplies industry

What country is Azenta based in?

Azenta is headquartered in United States

When did Azenta go public?

Azenta's initial public offering (IPO) was on 02 February 1995

Is Azenta in the S&P 500?

No, Azenta is not included in the S&P 500 index

Is Azenta in the NASDAQ 100?

No, Azenta is not included in the NASDAQ 100 index

Is Azenta in the Dow Jones?

No, Azenta is not included in the Dow Jones index

When was Azenta's last earnings report?

Azenta's most recent earnings report was on 12 November 2024

When does Azenta report earnings?

The next expected earnings date for Azenta is 7 February 2025

Should I buy Azenta stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions